ATE221066T1 - Heterozyklische verbindungen - Google Patents
Heterozyklische verbindungenInfo
- Publication number
- ATE221066T1 ATE221066T1 AT97925405T AT97925405T ATE221066T1 AT E221066 T1 ATE221066 T1 AT E221066T1 AT 97925405 T AT97925405 T AT 97925405T AT 97925405 T AT97925405 T AT 97925405T AT E221066 T1 ATE221066 T1 AT E221066T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- heterocyclic compounds
- sec
- date
- pub
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Earth Drilling (AREA)
- Stereophonic System (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1600896P | 1996-04-23 | 1996-04-23 | |
| PCT/US1997/006699 WO1997040044A1 (en) | 1996-04-23 | 1997-04-23 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE221066T1 true ATE221066T1 (de) | 2002-08-15 |
Family
ID=21774852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97925405T ATE221066T1 (de) | 1996-04-23 | 1997-04-23 | Heterozyklische verbindungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6117883A (de) |
| EP (1) | EP0900218B1 (de) |
| JP (1) | JP2000509046A (de) |
| AT (1) | ATE221066T1 (de) |
| AU (1) | AU3055397A (de) |
| CA (1) | CA2250873A1 (de) |
| DE (1) | DE69714247T2 (de) |
| DK (1) | DK0900218T3 (de) |
| ES (1) | ES2180998T3 (de) |
| WO (1) | WO1997040044A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| US6919447B2 (en) * | 2001-06-06 | 2005-07-19 | Weyerhaeuser Company | Hypochlorite free method for preparation of stable carboxylated carbohydrate products |
| US20050028953A1 (en) * | 2003-08-05 | 2005-02-10 | Severeid David E. | Methods for making carboxylated pulp fibers |
| US7001483B2 (en) * | 2003-08-05 | 2006-02-21 | Weyerhaeuser Company | Apparatus for making carboxylated pulp fibers |
| EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| WO1993014089A1 (en) * | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| WO1994018201A1 (fr) * | 1993-02-12 | 1994-08-18 | Sankyo Company, Limited | Derive d'isoxazoleoxy |
| ES2111197T3 (es) * | 1993-04-21 | 1998-03-01 | Tosoh Corp | 3,4-dioxi-1,2,5-tiadiazoles en parte utiles como fungicidas. |
| JPH07188017A (ja) * | 1993-09-30 | 1995-07-25 | Souyaku Gijutsu Kenkyusho:Kk | チアジアゾール誘導体を含有する抗ウイルス剤 |
| US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5821370A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
| US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
| WO1997020819A1 (en) * | 1995-12-06 | 1997-06-12 | Eli Lilly And Company | Composition for treating pain |
| WO1997034899A1 (en) * | 1996-03-19 | 1997-09-25 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
-
1997
- 1997-04-23 ES ES97925405T patent/ES2180998T3/es not_active Expired - Lifetime
- 1997-04-23 WO PCT/US1997/006699 patent/WO1997040044A1/en not_active Ceased
- 1997-04-23 AU AU30553/97A patent/AU3055397A/en not_active Abandoned
- 1997-04-23 EP EP97925405A patent/EP0900218B1/de not_active Expired - Lifetime
- 1997-04-23 DK DK97925405T patent/DK0900218T3/da active
- 1997-04-23 DE DE69714247T patent/DE69714247T2/de not_active Expired - Fee Related
- 1997-04-23 US US09/171,794 patent/US6117883A/en not_active Expired - Fee Related
- 1997-04-23 AT AT97925405T patent/ATE221066T1/de not_active IP Right Cessation
- 1997-04-23 JP JP9538276A patent/JP2000509046A/ja active Pending
- 1997-04-23 CA CA002250873A patent/CA2250873A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0900218A1 (de) | 1999-03-10 |
| DE69714247D1 (de) | 2002-08-29 |
| WO1997040044A1 (en) | 1997-10-30 |
| ES2180998T3 (es) | 2003-02-16 |
| EP0900218A4 (de) | 2001-05-23 |
| US6117883A (en) | 2000-09-12 |
| EP0900218B1 (de) | 2002-07-24 |
| DE69714247T2 (de) | 2003-01-23 |
| DK0900218T3 (da) | 2002-09-02 |
| CA2250873A1 (en) | 1997-10-30 |
| JP2000509046A (ja) | 2000-07-18 |
| AU3055397A (en) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69621831D1 (de) | Piperazinderivative als tachykinin antagonisten | |
| ATE201016T1 (de) | Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten | |
| EE03723B1 (et) | Sidesüsteem, mis sisaldab vahendid Interneti aadresside edastamiseks SMS-teenuse abil | |
| ATE273956T1 (de) | Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten | |
| MX9805253A (es) | Antagonistas del receptor de vitronectina. | |
| ID29230A (id) | Alat kompensasi tekanan untuk wadah dua-bagian | |
| AP9801312A0 (en) | 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist. | |
| BG103548A (en) | Vitronectine receptor antagonists | |
| MX9204233A (es) | Inhibidores de proteasa retroviral. | |
| ATE305781T1 (de) | Non-peptidische vasopressin via antagonisten | |
| DE69824433D1 (en) | Proteintyrosinphosphatase inhibitoren | |
| ZA974216B (en) | Process for the resolution of racemic ketamine. | |
| DK0702673T3 (da) | Benz(b)azepin-2,5-dioner anvendelige ved behandlingen af neurodegenerative forstyrrelser | |
| WO2002039118A8 (en) | Screening methods for bone morphogenetic mimetics | |
| DE69714247D1 (de) | Heterozyklische verbindungen | |
| ATE288909T1 (de) | Indolderivate verwendbar zur behandlung von u.a. osteoporosis | |
| BG107046A (en) | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans | |
| DE69725459D1 (de) | Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane | |
| ATE215084T1 (de) | Imidazopyridin-azolidinone | |
| DK0931161T3 (da) | Fremgangsmåde til biotransformation af colchicinoid-forbindelser til de tilsvarende 3-glycosylderivater | |
| EP0971885A4 (de) | Verfahren zur herstellung von indan-ähnlichen verbindungen | |
| IT1294710B1 (it) | Procedimento per la realizzazione di concime organico a partire dai rifiuti solidi urbani,dalla frazione organica degli stessi o da | |
| IL126548A0 (en) | Use of aspirochlorine or derivatives thereof as immunosuppressive agents | |
| ES1029880Y (es) | Cerradura para unica llave perfeccionada. | |
| TR199900672T2 (xx) | Benzotiofenlerin sentezi i�in i�lem. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |